homocysteine and Venous Thrombosis

homocysteine has been researched along with Venous Thrombosis in 122 studies

Research

Studies (122)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (14.75)18.2507
2000's81 (66.39)29.6817
2010's20 (16.39)24.3611
2020's3 (2.46)2.80

Authors

AuthorsStudies
Abdullah, SM; Akhter, MS; Biswas, A; Dobie, G; Hamali, HA; Iqbal, J; Mobarki, AA; Saxena, R1
Ames, PRJ; Arcaro, A; D'Andrea, G; Gentile, F; Iannaccone, L; Maraglione, M; Marottoli, V1
Shi, B; Zhang, M; Zhao, M1
Moiz, B1
Chang, YW; Li, ZF; Liu, SY; Shu, XJ; Wang, WH1
Ci, H; Ge, X; Song, W; Tian, G; Zhang, Y1
Cannegieter, SC; Hensen, ADO; Lijfering, WM; Rosendaal, FR; van Hylckama Vlieg, A1
Cabarkapa, VS; Ilic, TA; Lozanov-Crvenkovic, ZS; Mitic, GP; Salatic, IR; Vuckovic, BA1
Ali, Z; Fowler, DR; Troncoso, JC1
Ghaznavi, H; Samiei, S; Soheili, Z; Soltanpour, MS1
Chang, HG; Ji, SB; Ma, PJ; Su, LL; Tao, SB; Wang, CW1
Chae, H; Kim, H; Kim, M; Kim, Y; Lee, GD; Lee, JM; Lee, SY; Oh, YS; Park, J1
Cuoghi, C; Fiorini, M; Marcacci, M; Marchini, S; Pietrangelo, A; Ventura, P; Venturelli, G1
Cass, A; Gallagher, MP; Jardine, MJ; Kang, A; Kulshrestha, S; Navaneethan, SD; Nigwekar, SU; Perkovic, V; Strippoli, GF; Zoungas, S1
Corella, D; Ferrando, F; Gómez, I; Mira, Y; Vayá, A1
Kalathil, D; Musarrat, K; Varughese, GI1
Bharatkumar, VP; Christopher, R; Nagaraja, D; Noone, ML1
Antov, S; Arsov, T; Bosilkova, G; Dzhekova-Stojkova, S; Efinska-Mladenovska, O; Kedev, S; Kostovska, S; Krstevska, M; Petlichkovski, A; Spiroski, I; Spiroski, M; Strezova, A; Trajkov, D1
Lee, JS; Shin, JI1
Duan, ZQ; Fan, YY; He, JA; Hu, XH; Liu, CW; Xin, SJ; Yang, DH; Yang, J; Zhang, J; Zhang, Q; Zhang, ZS1
Alvandfar, D; Ravari, H; Saadat, S; Zafarghandi, MR1
Dokras, A; Mak, W1
Aydoğdu, M; Bukan, N; Ekim, N; Kanbay, A; Köktürk, N; Özyılmaz, E1
Casey, A; Schinzel, H; Walter, PK; Wilmanns, C1
Bonet, E; Carrasco, P; Morales-Suárez-Varela, MM; Plumé, G; Vayá, A1
Abraldes, JG; Candusso, M; Luciani, M; Monti, L; Nobili, V; Pancotti, S; Pietrobattista, A; Soldati, M; Torre, G1
Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A1
Ben Hamouda, H; Braham, H; Ghanmi, S; Hamza, HA; Hassine, M; Sfar, MT; Soua, H; Wannes, S1
Ardizzone, S; Bolzacchini, E; de Franchis, R; Dell'Era, A; Maconi, G; Russo, U1
Cao, Y; Geng, Z; Huang, L; Jiang, L; Liu, Y; Xu, D; Zhao, R; Zhou, J; Zhou, K1
Adamek, L; Domagala, TB; Nizankowska, E; Sanak, M; Szczeklik, A1
Gala, JL; Hainaut, P; Heusterspreute, M; Jaumotte, C; Lavenne, E; Moriau, M; Verhelst, D; Wallemacq, P; Zech, F1
Key, NS; McGlennen, RC1
Law, M; Morris, JK; Wald, DS2
Ames, PR; Amitrano, L; Annunziata, M; Antinolfi, I; Balzano, A; Brancaccio, V; Ferrara, F; Guardascione, MA; Iannaccone, L; Margaglione, M1
Aleksic, N; Cushman, M; Folsom, AR; Heckbert, SR; Psaty, BM; Rosamond, WD; Tsai, AW; Tsai, MY; Yanez, ND1
Ahmed, R; Choudhry, VP; Gupta, M; Gupta, S; Saxena, R1
Ridker, PM1
Blanco-Vaca, F; Cuquet, J; López, N; Mateo, J1
Arslan, D; Baslamisli, F; Canataroglu, A; Inal, T; Ozbek, S; Seydaoglu, G; Tanriverdi, K1
Al-Habboubi, H; Almawi, WY; Ameen, G; Tamim, H1
Harrington, DJ; Kapustin, SI; Papayan, LP; Savidge, GF; Shmeleva, VM; Sobczyńska-Malefora, A1
Cobelli, M; Marietta, M; Panini, R; Rosa, MC; Salvioli, G; Ventura, P1
Qiu, L; Song, YH; Yan, SK1
Hausmann, MJ; Rogachev, B; Tomer, A; Vorobiov, M; Zlotnik, M1
Blom, HJ; Den Heijer, M; Heil, SG; Kluijtmans, LA; Van Der Rijt-Pisa, BJ1
Frederiksen, J; Grande, P; Jensen, GB; Juul, K; Nordestgaard, BG; Schroeder, TV; Tybjaerg-Hansen, A1
Blom, HJ; den Heijer, M; Gellekink, H; Kluijtmans, LA1
Alexander, M; Gnanamuthu, C; Joseph, M; Vaid, U1
Han, FL; Li, Q; Wang, MT; Yao, XP1
Bhat, G; Costea, A1
Kotel'nikov, MV1
El Matri, L; Feki, M; Ghannouchi, M; Hamzaoui, K; Houman, H; Kaabachi, N; Mebazaa, A; Smiti-Khanfir, M1
Bowden, RG; Gentile, M; Wilborn, C; Wilson, R; Wyatt, FB1
Clarke, R; Den Heijer, M; Lewington, S1
Muller, AF; Srirajaskanthan, R; Winter, M1
Bakan, E; Becit, N; Keleş, S; Koçak, H; Koçoğullari, CU; Unlü, Y1
Dauzat, M; Gris, JC; Quéré, I1
Caprini, JA; Glase, CJ; Goldshteyn, S; Hathaway, K1
Belinchón, O; Bruscas, MJ; Cortés, A; Díaz DE Tuesta, AM; Marchena, PJ; Nieto, JA; Ribó, MD; Val, E1
Barberis, G; Drenkard, C; Gamron, S; Menso, E; Onetti, CM; Onetti, L; Villafañe, S1
Dávid, M; Habon, T; Keszthelyi, Z; Kovács, N; Losonczy, H; Nagy, A; Tóth, O1
Eichinger, S1
den Heijer, M1
Al Haddabi, H; Al Kindi, S; Bayoumi, R; Dennison, D; Muralitharan, S; Pathare, A1
Blom, HJ; Borm, GF; den Heijer, M; Keijzer, MB; Verhoef, P1
Franco, RF; Lourenço, DM; Maffei, FH; Morelli, VM; Pereira, AC; Rollo, HA; Vannucchi, H; Zago, MA1
Föger, B1
Cantürk, NZ; Celebi, A; Hülagü, OS; Karakaya, AT; Ozgür, O; Sentürk, O1
Blom, HJ; Bos, GM; Cattaneo, M; den Heijer, M; Eichinger, S; Gerrits, WB; Rosendaal, FR; Willems, HP1
Blom, HJ; Borm, GF; den Heijer, M; Hermus, AR; Keijzer, MB; Ueland, PM; Vollset, SE1
Feki, H; Feki, M; Ghorbel, IB; Houman, H; Kaabachi, N; Omar, S; Souissi, M1
Cattaneo, M2
D'Almeida, V; DA Silveira, RC; Lourenço, DM; Morelli, VM; Rodrigues, CA1
Abdella, N; Al Humood, S; Al Mazeedy, M; Al Wazzan, H; Marouf, R; Mojiminiyi, O; Qurtom, M1
Brouwer, JL; Lijfering, WM; van de Poel, MH; van der Meer, J; Veeger, NJ1
Abbate, R; Aito, S; Cominelli, E; Marcucci, R1
Castañon, MM; Kordich, L; Lauricella, AM; Quintana, I1
Bezemer, ID; Doggen, CJ; Rosendaal, FR; Vos, HL1
Goto, K; Hiratsuka, M; Ishii, M; Kanno, J; Kiyoshige, Y; Kure, S1
Gatt, A; Makris, M1
Cushman, M1
Blom, HJ; den Heijer, M; Gellekink, H1
Abbate, R; Gensini, GF; Gori, AM; Marcucci, R; Sofi, F1
Ageno, W; Dentali, F; Ghirarduzzi, A; Pesavento, R; Prandoni, P; Romualdi, E1
Jain Jamal, MN; Naushad, SM; Prasad, CK; Rama Devi, AR1
Blom, HJ; den Heijer, M; Gellekink, H; Hermus, AR; Muntjewerff, JW; Vermeulen, SH1
Blom, HJ; Cannegieter, SC; Christiansen, SC; Hammerstrøm, J; Naess, IA; Romundstad, PR; Rosendaal, FR1
Aydintuğ, OT; Duman, T; Düzgün, N; Ertuğrul, E; Köse, K; Morris, Y; Tutkak, H1
Bellet, E; Chassé, JF; Dupuy, E; Janbon, C; Molho-Sabatier, P; Quéré, I; Tobelem, G1
Baker, RI; Eikelboom, JW1
Arroliga, AC; Marelich, GP; Matthay, RA; Murin, S1
Coto, E; Pinto, CR; Soto, I; Urgelles, MF; Vargas, M1
Blom, HJ; Bos, GM; den Heijer, M; Gerrits, WB; Rosendaal, FR1
Bayle, C; Bellet, H; Caussé, E; Champagne, S; Couderc, F; Salvayre, R; Siri, N; Valdiguié, P1
Boer, J; Kolbach, DN1
Bauer, KA; Leonard, DG; Van Deerlin, VM; Wulf, GM1
Hall, TN; Leahy, MF; Ramakrishnan, LL1
Blom, HJ; Bos, GM; den Heijer, M; Gerrits, WB; Rosendaal, FR; Willems, HP1
Aarnoudse, JG; Lubbers, MF; van Doormaal, JJ1
Donnelly, JG; Rock, GA1
Ducros, V; Faure, H; Favier, A; Pernod, G; Polack, B; Schmitt, D1
Cable, GG1
Bresson-Vautrin, C; Chalopin, JM; Ducloux, D1
Devaraj, S; Jialal, I; Marangon, K; O'Byrne, D1
Auberger, K; Homberger, A; Junker, R; Koch, HG; Linnebank, M; Nabel, P; Nowak-Göttl, U; Schobess, R1
Grigg, AP1
Bos, GM; den Heijer, M; Willems, HP1
Aubard, Y; Cantaloube, M; Darodes, N1
Günther, G; Heller, C; Junker, R; Kreuz, W; Kurnik, K; Nowak-Göttl, U; Schobess, R1
Aras , O; Hanson, NQ; Tsai, MY; Yang, F1
Chang, CJ; Chiang, CW; Hsu, LA; Hsu, TS; Ko, YL; Kuo, CT; Lee, YS; Sun, CF1
Abbate, R; Brunelli, T; Fedi, S; Gensini, GF; Giusti, B; Marcucci, R; Pepe, G; Poli, D; Prisco, D1
Konetschny, R; Renner, W; Stanger, O; Weger, M1
Bucciarelli, P; Cattaneo, M; Lecchi, A; Lombardi, R; Mannucci, PM1
Ames, PR; Cappucci, G; Margaglione, M1
Cerbone, AM; Cirillo, F; Coppola, A; de Stefano, V; Di Minno, G; Madonna, P; Orefice, G1
Reitsma, PH; Rosendaal, FR; van Aken, BE1
Bellet, H; Bounameaux, H; Daurès, JP; Dauzat, M; de Moerloose, P; Gris, JC; Janbon, C; Laroche, JP; Mercier, E; Perneger, TV; Quéré, I; Schved, JF; Zittoun, J1
Dvorsak, B; Ekart, R; Gorenjak, M; Hojs, R; Pecovnik-Balon, B1

Reviews

23 review(s) available for homocysteine and Venous Thrombosis

ArticleYear
Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: an autopsy case report and review of literature.
    Forensic science international, 2014, Volume: 242

    Topics: Heterozygote; Homocysteine; Humans; Intracranial Thrombosis; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Obesity; Recurrence; Sickle Cell Trait; Venous Thrombosis; Young Adult

2014
Interventions for lowering plasma homocysteine levels in dialysis patients.
    The Cochrane database of systematic reviews, 2016, May-31, Issue:5

    Topics: Aged; Cardiovascular Diseases; Cause of Death; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Stroke; Venous Thrombosis; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2016
Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.
    Seminars in thrombosis and hemostasis, 2009, Volume: 35, Issue:7

    Topics: Adiponectin; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Contraceptives, Oral, Hormonal; Female; Homocysteine; Humans; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk Factors; Venous Thrombosis

2009
Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.
    Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:4

    Topics: Female; Homocysteine; Humans; Male; PubMed; Randomized Controlled Trials as Topic; Risk Factors; Venous Thrombosis; Vitamin B Complex

2012
Hyperhomocyst(e)inemia and Thrombophilia.
    Archives of pathology & laboratory medicine, 2002, Volume: 126, Issue:11

    Topics: Blood Coagulation Tests; Homocysteine; Humans; Hyperhomocysteinemia; Practice Guidelines as Topic; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thromboembolism; Thrombophilia; Venous Thrombosis

2002
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.
    BMJ (Clinical research ed.), 2002, Nov-23, Volume: 325, Issue:7374

    Topics: Cohort Studies; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Myocardial Ischemia; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Pulmonary Embolism; Risk Factors; Venous Thrombosis

2002
Inherited risk factors for venous thromboembolism: implications for clinical practice.
    Clinical cornerstone, 2002, Volume: 4, Issue:6

    Topics: Activated Protein C Resistance; Anticoagulants; Factor V; Homocysteine; Humans; Models, Statistical; Point Mutation; Prevalence; Prothrombin; Recurrence; Risk Factors; Thromboembolism; Venous Thrombosis

2002
The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2004, Volume: 11, Issue:3

    Topics: Adult; Homocysteine; Humans; Male; Mass Screening; Middle Aged; Myocardial Ischemia; Venous Thrombosis

2004
[Hyperhomocysteinemia: from theory and practice in the treatment of thrombophilias].
    Kardiologiia, 2004, Volume: 44, Issue:10

    Topics: Administration, Oral; Anticoagulants; Blood Coagulation Tests; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Marfan Syndrome; Multicenter Studies as Topic; Mutation; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Thrombophilia; Time Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 6

2004
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:2

    Topics: Case-Control Studies; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Polymorphism, Single Nucleotide; Risk; Venous Thrombosis

2005
Homocysteine and venous thrombosis.
    Seminars in vascular medicine, 2005, Volume: 5, Issue:2

    Topics: Biomarkers; Homocysteine; Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors; Venous Thrombosis

2005
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Orvosi hetilap, 2005, Oct-09, Volume: 146, Issue:41

    Topics: Adult; C-Reactive Protein; Cholesterol; Cysteine; Female; Fibrin; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Pedigree; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Threonine; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor

2005
Are B vitamins a risk factor for venous thromboembolism? Yes.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:2

    Topics: Homocysteine; Humans; Hyperhomocysteinemia; Recurrence; Risk Factors; Thromboembolism; Venous Thrombosis; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Deficiency

2006
Are B vitamins a risk factor for VTE? Perhaps.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:2

    Topics: Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thromboembolism; Venous Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Deficiency

2006
Hyperhomocysteinemia and venous thromboembolism.
    Seminars in thrombosis and hemostasis, 2006, Volume: 32, Issue:7

    Topics: Case-Control Studies; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Prospective Studies; Recurrence; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamins

2006
Hyperhomocysteinemia and venous thrombosis.
    Seminars in hematology, 2007, Volume: 44, Issue:2

    Topics: Female; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Retrospective Studies; Venous Thrombosis

2007
Epidemiology and risk factors for venous thrombosis.
    Seminars in hematology, 2007, Volume: 44, Issue:2

    Topics: Age Factors; Homocysteine; Humans; Incidence; Obesity; Pulmonary Embolism; Recurrence; Risk Factors; Venous Thrombosis

2007
Hereditary thrombophilia and venous thromboembolism.
    American journal of respiratory and critical care medicine, 1998, Volume: 158, Issue:5 Pt 1

    Topics: Antithrombin III Deficiency; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Mutation; Prevalence; Protein C; Protein C Deficiency; Protein S Deficiency; Prothrombin; Thrombophilia; Venous Thrombosis

1998
Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
    Thrombosis and haemostasis, 1998, Volume: 80, Issue:6

    Topics: Adult; Case-Control Studies; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Venous Thrombosis

1998
[Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Nederlands tijdschrift voor geneeskunde, 1999, Mar-13, Volume: 143, Issue:11

    Topics: Adult; Aged; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Pyridoxine; Randomized Controlled Trials as Topic; Venous Thrombosis; Vitamin B 12

1999
Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications.
    European journal of obstetrics, gynecology, and reproductive biology, 2000, Volume: 93, Issue:2

    Topics: Abortion, Habitual; Anticoagulants; Female; Fetal Death; Fetal Growth Retardation; Homocysteine; Humans; Neural Tube Defects; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Venous Thrombosis

2000
Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Clinical chemistry and laboratory medicine, 2001, Volume: 39, Issue:8

    Topics: Endothelium, Vascular; Free Radicals; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Models, Biological; Models, Chemical; Oxidative Stress; Vascular Diseases; Venous Thrombosis

2001
Hyperhomocysteinemia and thrombosis.
    Lipids, 2001, Volume: 36 Suppl

    Topics: Animals; Arteriosclerosis; Case-Control Studies; Cross-Sectional Studies; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thrombosis; Venous Thrombosis

2001

Trials

7 trial(s) available for homocysteine and Venous Thrombosis

ArticleYear
Effects of folic acid combined with vitamin B12 on DVT in patients with homocysteine cerebral infarction.
    European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:10

    Topics: Adult; Aged; Cerebral Infarction; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; International Normalized Ratio; Male; Middle Aged; Recurrence; Venous Thrombosis; Vitamin B 12

2017
Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow-up study.
    British journal of haematology, 2019, Volume: 187, Issue:2

    Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Recurrence; Risk Factors; Venous Thrombosis

2019
Hyperhomocysteinemia prevalence among patients with venous thromboembolism.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2011, Volume: 17, Issue:5

    Topics: Adult; Aged; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Risk Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency

2011
Effect of Helicobacter pylori infection on deep vein thrombosis seen in patients with Behçet's disease.
    East African medical journal, 2006, Volume: 83, Issue:1

    Topics: Adolescent; Adult; Behcet Syndrome; Case-Control Studies; Female; Helicobacter Infections; Helicobacter pylori; Homocysteine; Hospitals, Teaching; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Venous Thrombosis

2006
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.
    Blood, 2007, Jan-01, Volume: 109, Issue:1

    Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Proportional Hazards Models; Pulmonary Embolism; Pyridoxine; Recurrence; Risk Factors; Thrombophilia; Treatment Failure; Venous Thrombosis; Vitamin B 12

2007
Homocysteine reduction by B-vitamin supplementation increases t-PA and PAI-1 levels in patients with venous thromboembolism.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Dietary Supplements; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Pyridoxine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Vitamin B 12; Vitamin B Complex

2007
Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
    Seminars in thrombosis and hemostasis, 2000, Volume: 26, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Netherlands; Prospective Studies; Pulmonary Embolism; Pyridoxine; Retrospective Studies; Secondary Prevention; Thrombophilia; Thrombophlebitis; Treatment Outcome; Ultrasonography; Venous Thrombosis; Vitamin B 12

2000

Other Studies

92 other study(ies) available for homocysteine and Venous Thrombosis

ArticleYear
Endothelial Nitric Oxide Synthase Gene Polymorphisms Increase Risk of Deep Vein Thrombosis by Altering Homocysteine Levels.
    Clinical laboratory, 2022, Mar-01, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Genotype; Homocysteine; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Venous Thrombosis; Young Adult

2022
Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
    Digestive diseases and sciences, 2023, Volume: 68, Issue:4

    Topics: Aged; Cross-Sectional Studies; Genotype; Homocysteine; Humans; Liver Cirrhosis; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Portal Vein; Protein C; Retrospective Studies; Venous Thrombosis

2023
Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report.
    BMC neurology, 2023, Apr-19, Volume: 23, Issue:1

    Topics: Adolescent; Female; Folic Acid; Genotype; Heterozygote; Homocysteine; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Loss of Heterozygosity; Methylenetetrahydrofolate Reductase (NADPH2); Venous Thrombosis

2023
Homocysteine as a Biomarker for Thrombosis: What is the Learning Curve?
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2017, Volume: 27, Issue:3

    Topics: Biomarkers; Homocysteine; Humans; Learning Curve; Venous Thrombosis

2017
Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.
    Molecular medicine reports, 2017, Volume: 16, Issue:5

    Topics: Animals; Anticoagulants; Chlorides; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Ferric Compounds; Gene Expression Regulation; Homocysteine; Hydrogen Sulfide; Male; Matrix Metalloproteinase 9; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Venous Thrombosis

2017
Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.
    Croatian medical journal, 2013, Oct-28, Volume: 54, Issue:5

    Topics: Adolescent; Adult; Case-Control Studies; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Risk Factors; Venous Thrombosis; Young Adult

2013
Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2015, Volume: 26, Issue:8

    Topics: Adolescent; Adult; Aged; Alleles; Case-Control Studies; Fasting; Female; Gene Expression; Genetic Association Studies; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis

2015
An Increased Serum Level of Lipoprotein(a) Is a Predictor for Deep Vein Thrombosis in Patients with Spinal Cord Injuries.
    World neurosurgery, 2016, Volume: 87

    Topics: Adult; Asian People; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Risk Factors; Spinal Cord Injuries; Ultrasonography, Doppler, Color; Venous Thrombosis

2016
Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension.
    Annals of laboratory medicine, 2016, Volume: 36, Issue:3

    Topics: Adult; Aged; Antihypertensive Agents; DNA; Factor V; Female; Fibrin Fibrinogen Degradation Products; Genotype; Homocysteine; Humans; Hypertension; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Platelet Count; Polymorphism, Single Nucleotide; Prothrombin; Real-Time Polymerase Chain Reaction; Republic of Korea; Risk Factors; Vascular Diseases; Venous Thrombosis

2016
Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
    Thrombosis research, 2016, Volume: 141

    Topics: Aged; Carcinoma, Hepatocellular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Liver Cirrhosis; Liver Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Portal Vein; Retrospective Studies; Venous Thrombosis

2016
Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:6

    Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombophilia; Venous Thrombosis

2008
Metformin, B12 and homocysteine levels: the plausible cause or effect?
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2008, Volume: 107, Issue:6

    Topics: Homocysteine; Humans; Hyperhomocysteinemia; Metformin; Venous Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency

2008
Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis.
    Journal of the neurological sciences, 2008, Sep-15, Volume: 272, Issue:1-2

    Topics: Adolescent; Adult; Confidence Intervals; Female; Folic Acid; Homocysteine; Humans; Intracranial Thrombosis; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Prothrombin; Puerperal Disorders; Risk; Risk Assessment; Statistics as Topic; Venous Thrombosis; Vitamin B 12

2008
Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
    Acta biochimica Polonica, 2008, Volume: 55, Issue:3

    Topics: Adult; Aged; Arterial Occlusive Diseases; Case-Control Studies; Female; Genotype; Haplotypes; Heterozygote; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Republic of North Macedonia; Venous Thrombosis

2008
High factor VIII or homocysteine levels and thrombosis in Henoch-Schönlein purpura.
    Rheumatology international, 2009, Volume: 29, Issue:10

    Topics: Adolescent; Biomarkers; Coagulation Protein Disorders; Factor VIII; Homocysteine; Humans; IgA Vasculitis; Male; Venous Thrombosis; von Willebrand Factor

2009
Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2010, Volume: 39, Issue:4

    Topics: Acute Disease; Adult; Aged; Asian People; Biomarkers; Case-Control Studies; Chi-Square Distribution; China; Chromatography, High Pressure Liquid; Down-Regulation; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Immunoassay; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Risk Assessment; Risk Factors; Venous Thrombosis; Vitamin B 12; Young Adult

2010
Serum homocysteine in deep venous thrombosis, peripheral atherosclerosis and healthy Iranians: a case-control study.
    Pakistan journal of biological sciences : PJBS, 2009, Jul-15, Volume: 12, Issue:14

    Topics: Adult; Atherosclerosis; Case-Control Studies; Female; Homocysteine; Humans; Iran; Male; Middle Aged; Ultrasonography, Doppler, Duplex; Venous Thrombosis

2009
Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase.
    Phlebology, 2011, Volume: 26, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Factor V; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Mutation, Missense; Prothrombin; Thrombophlebitis; Varicose Veins; Venous Thrombosis

2011
Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis.
    European journal of haematology, 2011, Volume: 86, Issue:2

    Topics: Adult; Cholesterol; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Mutation; Spain; Splanchnic Circulation; Venous Thrombosis

2011
Extrahepatic portal vein thrombosis in children and adolescents: Influence of genetic thrombophilic disorders.
    World journal of gastroenterology, 2010, Dec-28, Volume: 16, Issue:48

    Topics: Adolescent; Case-Control Studies; Child; Homocysteine; Humans; Male; Portal Vein; Prospective Studies; Protein C; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis

2010
Altered fibrin clot properties in patients with retinal vein occlusion.
    Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:12

    Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis

2011
[Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and the MTHFR gene mutation].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2012, Volume: 19, Issue:4

    Topics: Diagnosis, Differential; DNA Mutational Analysis; Factor V; Genetic Carrier Screening; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Homozygote; Humans; Infant, Newborn; Male; Methylenetetrahydrofolate Reductase (NADPH2); Renal Veins; Thrombophilia; Venous Thrombosis

2012
Portal vein thrombosis in inflammatory bowel diseases: a single-center case series.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3

    Topics: Adult; Anticoagulants; Colitis, Ulcerative; Crohn Disease; Female; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Portal Vein; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thrombosis; von Willebrand Factor

2012
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:5

    Topics: 3' Untranslated Regions; Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Codon; Factor V; Fasting; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Poland; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis

2002
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
    Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Belgium; Case-Control Studies; Fasting; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prospective Studies; Protein C Deficiency; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis

2002
Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    American journal of hematology, 2003, Volume: 72, Issue:2

    Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation Factor Inhibitors; Case-Control Studies; Comorbidity; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myeloproliferative Disorders; Prevalence; Retrospective Studies; Splanchnic Circulation; Thrombophilia; Venous Thrombosis

2003
Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE).
    American journal of hematology, 2003, Volume: 72, Issue:3

    Topics: Aged; Aging; Animals; Case-Control Studies; Cohort Studies; Factor V; Female; Genotype; Homocysteine; Humans; Longitudinal Studies; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prospective Studies; Risk Factors; Venous Thrombosis

2003
Familial hyperhomocysteinemia: multiple venous thrombosis in four generations of a family.
    Annals of hematology, 2003, Volume: 82, Issue:3

    Topics: Adult; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nitroprusside; Pedigree; Venous Thrombosis; Vitamin B 12; Warfarin

2003
Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N-acetylcysteine therapy.
    Journal of internal medicine, 2003, Volume: 254, Issue:4

    Topics: Acetylcysteine; Fatal Outcome; Fibrinolytic Agents; Homocysteine; Humans; Male; Middle Aged; Pulmonary Embolism; Streptokinase; Thrombosis; Venous Thrombosis

2003
Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease.
    Rheumatology international, 2003, Volume: 23, Issue:5

    Topics: Adult; Behcet Syndrome; Female; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Venous Thrombosis

2003
A common mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in two Arab communities.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:10

    Topics: Adult; Arabs; Bahrain; Coronary Artery Disease; Female; Genetic Variation; Genetics, Population; Genotype; Homocysteine; Humans; Lebanon; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Venous Thrombosis

2003
Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia.
    Thrombosis research, 2003, Volume: 111, Issue:6

    Topics: Adolescent; Adult; Aged; Blood Coagulation; Female; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Retrospective Studies; Russia; Thrombosis; Venous Thrombosis

2003
Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis.
    Cerebrovascular diseases (Basel, Switzerland), 2004, Volume: 17, Issue:2-3

    Topics: Adult; Antithrombin III; Cerebral Veins; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Male; Point Mutation; Prevalence; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis

2004
[Hyperhomocysteinemia and deep-vein thrombosis].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2003, Volume: 25, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Restriction Fragment Length; Venous Thrombosis; Vitamin B 12

2003
Increased coagulation factor levels leading to allograft renal vein thrombosis.
    Clinical nephrology, 2004, Volume: 61, Issue:3

    Topics: Blood Coagulation Factors; Factor IX; Factor VII; Factor VIII; Factor XI; Graft Rejection; Graft Survival; Homocysteine; Humans; Kidney Transplantation; Male; Middle Aged; Renal Veins; Venous Thrombosis

2004
The 894 G > T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:5

    Topics: Case-Control Studies; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Molecular Epidemiology; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrosation; Odds Ratio; Polymorphism, Single Nucleotide; Recurrence; Risk; Venous Thrombosis

2004
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.
    Blood, 2004, Nov-15, Volume: 104, Issue:10

    Topics: Adult; Case-Control Studies; Denmark; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Prospective Studies; Risk Factors; Venous Thrombosis

2004
Effect of genetic variation in the human S-adenosylhomocysteine hydrolase gene on total homocysteine concentrations and risk of recurrent venous thrombosis.
    European journal of human genetics : EJHG, 2004, Volume: 12, Issue:11

    Topics: Adenosylhomocysteinase; Base Composition; Case-Control Studies; Chromosome Mapping; DNA Mutational Analysis; Genetic Variation; Homocysteine; Humans; Risk; Venous Thrombosis

2004
Recurrent cerebral venous and peripheral arterial thrombosis.
    Neurology India, 2004, Volume: 52, Issue:2

    Topics: Adolescent; Cerebral Veins; Female; Femoral Artery; Homocysteine; Humans; Magnetic Resonance Angiography; Thrombophilia; Thrombosis; Venous Thrombosis

2004
[Relationship of plasma homocysteine and folic acid levels and 5,10-methylenetetrahydrofolate reductase gene mutation with venous thromboembolism].
    Zhonghua nei ke za zhi, 2004, Volume: 43, Issue:8

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Case-Control Studies; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Middle Aged; Mutation; Venous Thrombosis

2004
Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report.
    American journal of hematology, 2004, Volume: 77, Issue:2

    Topics: Adult; Anticoagulants; Enoxaparin; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Treatment Outcome; Venous Thrombosis

2004
Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease.
    Clinical chemistry and laboratory medicine, 2004, Volume: 42, Issue:12

    Topics: Adolescent; Adult; Aged; Behcet Syndrome; Cohort Studies; Comorbidity; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Tunisia; Uveitis; Venous Thrombosis

2004
Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients.
    Renal failure, 2004, Volume: 26, Issue:6

    Topics: Age Distribution; Aged; Analysis of Variance; Arteriovenous Shunt, Surgical; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Probability; Renal Dialysis; Retrospective Studies; Risk Assessment; Sex Distribution; Statistics, Nonparametric; Venous Thrombosis

2004
Venous thrombosis in inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:7

    Topics: Blood Coagulation Disorders; Colitis, Ulcerative; Crohn Disease; Factor V; Homocysteine; Humans; Inflammatory Bowel Diseases; Mutation; Prothrombin; Risk Factors; Venous Thrombosis

2005
Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2005, Volume: 30, Issue:3

    Topics: Adult; Aged; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Retrospective Studies; Risk Factors; Venous Thrombosis

2005
Thrombophilia testing in patients with venous thrombosis.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2005, Volume: 30, Issue:5

    Topics: Blood Coagulation Factor Inhibitors; Factor V; Genetic Markers; Genetic Testing; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Prothrombin; Recurrence; Thrombophilia; Venous Thrombosis

2005
Low levels of vitamin B12 and venous thromboembolic disease in elderly men.
    Journal of internal medicine, 2005, Volume: 258, Issue:3

    Topics: Age Factors; Aged; Biomarkers; Case-Control Studies; Creatinine; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Risk Assessment; Thromboembolism; Venous Thrombosis; Vitamin B 12; Vitamin B Deficiency

2005
[Hyperhomocysteine like thrombocytic risk factor in patient with systemic lupus erythematous with antiphospholipid syndrome].
    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2005, Volume: 62, Issue:1

    Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Argentina; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Thrombosis; Venous Thrombosis

2005
Hereditary thrombophilia in ethnic Omani patients.
    American journal of hematology, 2006, Volume: 81, Issue:2

    Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders, Inherited; Blood Proteins; Case-Control Studies; Child; DNA Mutational Analysis; Female; Homocysteine; Humans; Male; Middle Aged; Oman; Pulmonary Embolism; Thrombophilia; Thrombosis; Venous Thrombosis

2006
No added value of the methionine loading task in assessment for venous thrombosis and cardiovascular disease risk.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:2

    Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Practice Guidelines as Topic; Risk; ROC Curve; Venous Thrombosis

2006
A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study).
    Thrombosis research, 2007, Volume: 119, Issue:2

    Topics: Adolescent; Adult; Aged; Brazil; Child; Child, Preschool; DNA Mutational Analysis; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Risk; Transcobalamins; Venous Thrombosis

2007
The FIELD study.
    Lancet (London, England), 2006, Apr-08, Volume: 367, Issue:9517

    Topics: Diabetes Mellitus, Type 2; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Risk Factors; Venous Thrombosis

2006
Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis.
    Thrombosis and haemostasis, 2006, Volume: 96, Issue:4

    Topics: Adult; Aged; Case-Control Studies; Cysteine; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Methylation; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Risk Assessment; Risk Factors; Venous Thrombosis

2006
Hyperhomocysteinemia is associated with deep venous thrombosis of the lower extremities in Tunisian patients.
    Clinical biochemistry, 2007, Volume: 40, Issue:1-2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Creatinine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Leg; Male; Middle Aged; Prevalence; Recurrence; Tunisia; Venous Thrombosis; Vitamin B 12

2007
Plasma homocysteine and hematological factors in patients with venous thromboembolic diseases in Kuwait.
    Acta haematologica, 2007, Volume: 117, Issue:2

    Topics: Activated Protein C Resistance; Adult; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kuwait; Male; Protein C; Protein S; Thromboembolism; Venous Thrombosis

2007
Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cohort Studies; Fasting; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Methionine; Middle Aged; Netherlands; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Venous Thrombosis

2007
Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries.
    Spinal cord, 2007, Volume: 45, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Italy; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Spinal Cord Injuries; Treatment Outcome; Venous Thrombosis

2007
Plasma homocysteine cutoff values for venous thrombosis.
    Clinical chemistry and laboratory medicine, 2007, Volume: 45, Issue:2

    Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Venous Thrombosis

2007
No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Archives of internal medicine, 2007, Mar-12, Volume: 167, Issue:5

    Topics: Adolescent; Adult; Aged; Alleles; Biomarkers; DNA; Factor V; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Incidence; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Netherlands; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Prothrombin; Pulmonary Embolism; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Venous Thrombosis

2007
Inherited risk factors for deep venous thrombosis following total hip arthroplasty in Japanese patients: matched control study.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2007, Volume: 12, Issue:2

    Topics: Aged; Arthroplasty, Replacement, Hip; Case-Control Studies; Factor V; Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic; Postoperative Complications; Protein C; Risk Factors; Venous Thrombosis

2007
Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis
    Clinical chemistry and laboratory medicine, 2007, Volume: 45, Issue:4

    Topics: Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Hydroxymethyl and Formyl Transferases; Membrane Transport Proteins; Multienzyme Complexes; Nucleotide Deaminases; Polymorphism, Genetic; Reduced Folate Carrier Protein; Thymidylate Synthase; Venous Thrombosis

2007
Vitamin supplementation in the secondary prevention of venous thromboembolism: about the VITRO study.
    Blood, 2007, Jun-15, Volume: 109, Issue:12

    Topics: Clinical Trials as Topic; Dietary Supplements; Homocysteine; Humans; Thrombophilia; Venous Thrombosis; Vitamins

2007
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study.
    Haematologica, 2007, Volume: 92, Issue:9

    Topics: Aged; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Venous Thrombosis

2007
Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
    Clinical chemistry and laboratory medicine, 2008, Volume: 46, Issue:1

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Base Sequence; Case-Control Studies; Cohort Studies; Female; Ferredoxin-NADP Reductase; Genotype; Heterozygote; Homocysteine; Humans; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Venous Thrombosis

2008
Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:6

    Topics: Adult; Aged; Case-Control Studies; Catechol O-Methyltransferase; Female; Gene Frequency; Genotype; Haplotypes; Homocysteine; Humans; Linkage Disequilibrium; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Recurrence; Risk Assessment; Risk Factors; Venous Thrombosis

2007
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
    British journal of haematology, 2008, Volume: 141, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Epidemiologic Methods; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pulmonary Embolism; Venous Thrombosis

2008
Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease.
    Clinical rheumatology, 2008, Volume: 27, Issue:10

    Topics: Adolescent; Adult; Behcet Syndrome; Case-Control Studies; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Promoter Regions, Genetic; Tandem Repeat Sequences; Thymidylate Synthase; Venous Thrombosis; Young Adult

2008
[Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine].
    La Revue de medecine interne, 1998, Volume: 19, Issue:1

    Topics: Adult; Aged; Antithrombin III; Chromatography, Ion Exchange; Data Interpretation, Statistical; Female; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Protein C; Protein S; Risk Factors; Serine Proteinase Inhibitors; Surveys and Questionnaires; Venous Thrombosis

1998
Venous thrombosis and hyperhomocysteinaemia.
    The Medical journal of Australia, 1998, Sep-21, Volume: 169, Issue:6

    Topics: Adult; Anticoagulants; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Recurrence; Risk Factors; Venous Thrombosis; Vitamin B 12

1998
Mild hyperhomocysteinemia and MTHFR C677T do not increase the risk for venous thrombosis in a Spanish population.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1998, Volume: 9, Issue:6

    Topics: Adult; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Spain; Venous Thrombosis

1998
Plasma homocysteine determined by capillary electrophoresis with laser-induced fluorescence detection.
    Clinical chemistry, 1999, Volume: 45, Issue:3

    Topics: Coronary Disease; Electrophoresis, Capillary; Fluorescence; Homocysteine; Humans; Lasers; Reproducibility of Results; Venous Thrombosis

1999
[A young patient with chronic recurrent leg ulcers; hyperhomocysteinemia and heterozygote for factor V Leiden].
    Nederlands tijdschrift voor geneeskunde, 1998, Dec-05, Volume: 142, Issue:49

    Topics: Adult; Anticoagulants; Bandages; Chronic Disease; Factor V; Folic Acid; Genetic Carrier Screening; Genetic Predisposition to Disease; Homocysteine; Humans; Leg Ulcer; Male; Metabolism, Inborn Errors; Secondary Prevention; Venous Thrombosis

1998
Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:2

    Topics: 3' Untranslated Regions; Adolescent; Antithrombins; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Factor V; Female; Heterozygote; Homocysteine; Homozygote; Humans; Male; Middle Aged; Mutation; Nuclear Family; Prothrombin; Saphenous Vein; Venous Thrombosis; Warfarin

1999
Thermolabile methyltetrahydrofolate reductase associated with unusual venous and arterial thromboses.
    Pathology, 1999, Volume: 31, Issue:1

    Topics: Adult; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Thrombosis; Venous Thrombosis

1999
[Obstetric problems followed by stroke].
    Nederlands tijdschrift voor geneeskunde, 1999, Apr-03, Volume: 143, Issue:14

    Topics: Abortion, Habitual; Adult; Arteriosclerosis; Cerebral Infarction; Diagnosis, Differential; Female; Fetal Death; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Infant, Newborn; Male; Methionine; Nutrition Disorders; Placental Insufficiency; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridoxine; Smoking; Venous Thrombosis; Vitamin B 6 Deficiency

1999
Genetic determinants of heritable venous thrombosis: genotyping methods for factor V(Leiden)A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations.
    Clinical biochemistry, 1999, Volume: 32, Issue:3

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Algorithms; Base Sequence; DNA Primers; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases; Polymerase Chain Reaction; Prothrombin; Venous Thrombosis

1999
Gas chromatographic-mass spectrometric determination of total homocysteine in human plasma by stable isotope dilution: method and clinical applications.
    Journal of chromatography. B, Biomedical sciences and applications, 1999, Jun-11, Volume: 729, Issue:1-2

    Topics: Adult; Calibration; Case-Control Studies; Cerebrovascular Disorders; Female; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Isotopes; Male; Middle Aged; Reference Values; Reproducibility of Results; Venous Thrombosis

1999
Hyperhomocysteinaemia and upper extremity deep venous thrombosis: a case report.
    Aviation, space, and environmental medicine, 1999, Volume: 70, Issue:7

    Topics: Adult; Aerospace Medicine; Axillary Vein; Causality; Dehydration; Disability Evaluation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Military Personnel; Occupational Diseases; Physical Exertion; Recurrence; South Australia; Subclavian Vein; Ultrasonography; Venous Thrombosis

1999
Ocular venous occlusion and hyperhomocysteinemia.
    Annals of internal medicine, 1999, Oct-05, Volume: 131, Issue:7

    Topics: Homocysteine; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Retinal Vein; Venous Thrombosis

1999
Validation of an immunoassay for measurement of plasma total homocysteine.
    American journal of clinical pathology, 1999, Volume: 112, Issue:6

    Topics: Autoanalysis; Bilirubin; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Freezing; Homocysteine; Humans; Quality Control; Renal Insufficiency; Risk Factors; Sensitivity and Specificity; Smoking; Triglycerides; Venous Thrombosis

1999
The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    European journal of pediatrics, 1999, Volume: 158 Suppl 3

    Topics: Adolescent; Age of Onset; Alleles; Case-Control Studies; Child; Child, Preschool; Factor V; Female; Genetic Predisposition to Disease; Genotype; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Infant; Infant, Newborn; Male; Methylenetetrahydrofolate Reductase (NADPH2); Multifactorial Inheritance; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Prothrombin; Risk Factors; Statistics, Nonparametric; Venous Thrombosis

1999
Deep venous thrombosis as the presenting feature in a patient with coeliac disease and homocysteinaemia.
    Australian and New Zealand journal of medicine, 1999, Volume: 29, Issue:4

    Topics: Adult; Celiac Disease; Folic Acid Deficiency; Homocysteine; Humans; Male; Recurrence; Venous Thrombosis

1999
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
    British journal of haematology, 2000, Volume: 111, Issue:2

    Topics: Antibodies, Anticardiolipin; Antithrombins; Budd-Chiari Syndrome; Case-Control Studies; Confidence Intervals; Factor V; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Infant; Infant, Newborn; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Portal Vein; Prospective Studies; Protein C; Protein S; Prothrombin; Renal Veins; Venous Thrombosis

2000
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Clinical chemistry, 2001, Volume: 47, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Coronary Disease; Fasting; Female; Fluorometry; Genotype; Homocysteine; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prevalence; Venous Thrombosis

2001
Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
    Thrombosis research, 2001, Jun-01, Volume: 102, Issue:5

    Topics: Adult; Aged; Case-Control Studies; Factor V; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors; Taiwan; Thromboembolism; Thrombophilia; Venous Thrombosis

2001
The role of cysteine and homocysteine in venous and arterial thrombotic disease.
    American journal of clinical pathology, 2001, Volume: 116, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Arteries; Cysteine; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Reference Values; Thrombosis; Venous Thrombosis

2001
Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis.
    Circulation, 2001, Nov-13, Volume: 104, Issue:20

    Topics: Adolescent; Adult; Aged; Child; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Middle Aged; Risk Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 6

2001
Comparative prevalence of antiphospholipid antibodies and thrombophilic genotypes in consecutive patients with venous thrombosis.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2001, Volume: 12, Issue:8

    Topics: Adult; Age of Onset; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Homocysteine; Humans; Male; Prevalence; Risk Factors; Thrombophilia; Venous Thrombosis

2001
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.
    Stroke, 2002, Volume: 33, Issue:1

    Topics: Adult; Brain Ischemia; Factor V; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prothrombin; Risk Factors; Stroke; Venous Thrombosis

2002
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis.
    British journal of haematology, 2002, Volume: 116, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Anticoagulants; C-Reactive Protein; Case-Control Studies; Factor VIII; Female; Homocysteine; Humans; Interleukin-8; Male; Middle Aged; Odds Ratio; Risk; Risk Factors; Sex Factors; Venous Thrombosis

2002
Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
    Lancet (London, England), 2002, Mar-02, Volume: 359, Issue:9308

    Topics: Adult; Aged; Case-Control Studies; Erythrocytes; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Pulmonary Embolism; Risk Factors; Tetrahydrofolates; Venous Thrombosis

2002
Homocysteine and vascular access thrombosis in hemodialysis patients.
    Renal failure, 2002, Volume: 24, Issue:2

    Topics: Adult; Aged; Arteriovenous Fistula; Catheters, Indwelling; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Time Factors; Venous Thrombosis

2002